| Target Price | $35.70 |
| Price | $2.10 |
| Potential |
1,600.00%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target IN8bio Inc 2026 .
The average IN8bio Inc target price is $35.70.
This is
1,600.00%
register free of charge
$189.00
8,900.00%
register free of charge
$3.03
44.29%
register free of charge
|
|
| A rating was issued by 10 analysts: 9 Analysts recommend IN8bio Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the IN8bio Inc stock has an average upside potential 2026 of
1,600.00%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -17.05 | -5.51 |
| 43.45% | 67.68% | |
| P/E | negative |
6 Analysts have issued a IN8bio Inc forecast for earnings per share. The average IN8bio Inc EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 14 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Feb 12 2025 |
| Jones Trading |
Locked
➜
Locked
|
Locked | Feb 11 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 26 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 13 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 14 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Feb 12 2025 |
|
Locked
Jones Trading:
Locked
➜
Locked
|
Feb 11 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 26 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 13 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


